日本SRL, Inc.
1970.06(S45)創設于日本東京都,營業主體為臨床檢體檢查,受托檢驗常態項目一千五百項,加上特殊檢查超過四千項,每日檢體數超過十四萬支,年營業額為日幣1100億。 為全亞洲第一家通過美國CAP認定的檢驗中心。
2005年7月,領先的體外診療公司Fujirebio Inc.與日本一流的臨床試驗服務供應商SRL, Inc合并成立富吉瑞必歐。富吉瑞必歐Fujirebio的分銷網絡覆蓋全球,為全世界的醫生和患者提供診斷產品。
SRL, Inc. is the leading company in Japan that provides comprehensive laboratory testing services. Specifically, these services include the receipt of specimens from patients at hospitals, testing the specimens, and reporting the results and related research information back to the hospitals. These results are used in virtually every aspect of medical treatment and evaluation including the diagnosis of diseases, identification of physical conditions, choosing courses of treatment and monitoring the progress of treatments.
With its remarkable degree of advanced technological and research capabilities, SRL is currently able to offer more than 5,000 types of clinical laboratory tests, ranging from general testing to esoteric testing including gene-based tests. The SRL Group network consists of an Esoteric Testing Laboratory Complex, eight regional clinical laboratory testing companies, 140 in-hospital laboratories, and 160 branch offices, where specimens are collected. Through its nation wide network, SRL provides diagnostic testing and information services to clinics, large hospitals, medical product manufacturers, and research institutions. The SRL Group is also very active in the areas of medical services such as sterilizing medical instruments and hospital outsourcing services.